Department of Medical Statistics
Project ESCAPE: Work Package 5 - Statistical Analysis and Health Economics
The Department of Medical Statistics is leading work package 5 together with the Institute of Health Economics and Clinical Epidemiology at the University Hospital of Cologne.
See here the current status of the work package.
Discussion Paper "On the role of data, statistics and decisions in a pandemic"
This discussion paper was prepared with the participation of Prof. Tim Friede and published in the current issue of the journal "Advances in Statistical Analysis".
The aim of this paper is to provide an overview of decision-making processes during a pandemic and to make recommendations on this from a statistical perspective.
See article "On the role of data, statistics and decisions in a pandemic".
Statement on the systematic review "The serotonin theory of depression"
In a recent article of the NZZ (Neue Zürcher Zeitung), Professor Friede comments on the systematic review "The serotonin theory of depression".
See article "Serotonin deficiency probably does not lead to depression after all" (in German, free registration required).
Participation in the EARLY-PROTECT-ALPORT study
The EARLY-PROTECT-ALPORT study proves that children with Alport syndrome can be treated safely and effectively at an early age.
In an interview, Professor Tim Friede explains the importance of choosing the right statistical methods. Read the interview.
In a video contribution, the project is presented by the project leader, Professor Oliver Gross from the University Medical Center Göttingen. See the video.
Neuroscience Yearbook 2021/2022
The yearbook 2021/22 of the Neuroscience program, of which Prof. Friede is member, is available. This booklet contains general information on the program as well as profiles of all students and faculty members of the program.
Participation in the international pancreatic cancer study METAPANC
The Department of Medical Statistics is participating in the international pancreatic cancer study METAPANC of the UMG, which is funded by the German Research Foundation. The aim of this multi-centre study is to investigate whether a multimodal therapy, which includes chemotherapy and tumour and metastasis resection, can improve the survival and quality of life of pancreatic cancer patients.